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Arrhythmogenic right ventricular
cardiomyopathy in patients
with biallelic JUP‑associated skin
fragility
Hassan Vahidnezhad1,2,3,15, Leila Youssefian1,2,4,5,15, Masoomeh Faghankhani1,2,
Nikoo Mozafari6, Amir Hossein Saeidian1,2,4, Fatemeh Niaziorimi1,2, Fahimeh Abdollahimajd6,
Soheila Sotoudeh7, Fateme Rajabi6, Liaosadat Mirsafaei8, Zahra Alizadeh Sani9, Lu Liu10,
Alyson Guy10, Sirous Zeinali3,11, Ariana Kariminejad12, Reginald T. Ho13, John A. McGrath14 &
Jouni Uitto1,2*
Arrhythmogenic right ventricular cardiomyopathy (ARVC), with skin manifestations, has been
associated with mutations in JUP encoding plakoglobin. Genotype–phenotype correlations regarding
the penetrance of cardiac involvement, and age of onset have not been well established. We examined
a cohort of 362 families with skin fragility to screen for genetic mutations with next-generation
sequencing-based methods. In two unrelated families, a previously unreported biallelic mutation,
JUP: c.201delC; p.Ser68Alafs*92, was disclosed. The consequences of this mutation were determined
by expression profiling both at tissue and ultrastructural levels, and the patients were evaluated
by cardiac and cutaneous work-up. Whole-transcriptome sequencing by RNA-Seq revealed JUP as
the most down-regulated gene among 21 skin fragility-associated genes. Immunofluorescence
showed the lack of plakoglobin in the epidermis. Two probands, 2.5 and 22-year-old, with the same
homozygous mutation, allowed us to study the cross-sectional progression of cardiac involvements
in relation to age. The older patient had anterior T wave inversions, prolonged terminal activation
duration (TAD), and RV enlargement by echocardiogram, and together with JUP mutation met
definite ARVC diagnosis. The younger patient had no evidence of cardiac disease, but met possible
ARVC diagnosis with one major criterion (the JUP mutation). In conclusion, we identified the same
biallelic homozygous JUP mutation in two unrelated families with skin fragility, but cardiac findings
highlighted age-dependent penetrance of ARVC. Thus, young, phenotypically normal patients with
biallelic JUP mutations should be monitored for development of ARVC.
Abbreviations
ALVC	Arrhythmogenic left ventricular cardiomyopathy
ARVC	Arrhythmogenic right ventricular cardiomyopathy
CMRI	Cardiac magnetic resonance imaging
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Cardiac involvement

Age at cardiac
presentation

Skin fragility, PPK,
sparse woolly hair, nail
dystrophy

–

N/A

Ex 2

Skin fragility, PPK,
sparse woolly hair, nail
dystrophy

–

N/A

p.Ser24*

Ex 2

Skin fragility, PPK,
sparse woolly hair, nail
dystrophy

DCM (left)

19 y

18 d¶

p.Gln184*

Ex 4

Skin fragility, alopecia,
nail dystrophy

Perivascular fibrosis
myocyte dropout**

N/A

N/R13

12 d¶

p.Gln539*

Ex 9

Skin fragility, alopecia,
onycholysis

Unkown

N/A

2

Turkey29

34–46 y

p.Arg265His

Ex 5

NEPPK, alopecia

ARVC

20 y, N/R

7

7

France-Canada30

12–77 y

p.Glu301Gly

Ex 5

NEPPK, woolly hair

ARVC

18 y–48 y

8

19+

Greece7

N/R

p.Trp680Glyfs*11

Ex 12

NEPPK, woolly hair

ARVC

N/R

9

28+

Greece11

1–61 y

p.Trp680Glyfs*11

Ex 12

NEPPK, woolly hair

ARVC

12–68 y

Ex 2

Skin fragility, PPK, aloUncertain, ARVC
pecia, nail dystrophy

Family No

No. of patients

Country of Origin

Age

Mutation

Exon/Intron

1

2

Kuwait15

6 m, 12 m

p.468G > A

Ex 3#

2

3§

Argentina15

2–11 y

p.Ser24*

3

1§

Argentina12

17 y

4

1

N/R14

5

1

6

10

2

Iran

(this study)

2.5 y, 22 y

*

p.Ser68Alafs 92

Integumentary
manifestation

N/A

Table 1.  Summary of previously reported patients with biallelic homozygous JUP mutations presented with
concomitant skin and cardiac manifestations. § , + : The patients are shared; ¶: deceased; d: day; m: month; y:
year; N/R: Not reported; N/A: Not available; NEPPK: Non-epidermolytic palmoplantar keratoderma; ARVC:
Arrhythmogenic right ventricular cardiomyopathy; DCM: Dilated cardiomyopathy. # Synonymous mutation at
the border of exon 3 and IVS 3 resulted in aberrant splicing. **The results of post-mortem autopsy.

DCM	Dilated cardiomyopathy
TAD	Terminal activation duration
EB	Epidermolysis bullosa
LOF	Loss-of-function
NGS	Next generation sequencing
PPK	Palmoplantar keratoderma
ROH	Runs of homozygosity
Arrhythmogenic right ventricular cardiomyopathy (ARVC), which constitutes up to 20% of sudden cardiac death
cases in individuals under 30 years of age, is an inherited cardiac disease characterized by progressive fibrofatty
replacement of right ventricular myocardium that increases the risk of ventricular tachycardia and early-onset
sudden death1. This disease has an autosomal dominant mode of inheritance with considerably reduced penetrance with an estimated prevalence of 1:1000 to 1:5000 in the general population2–4. ARVC shows extensive
genetic heterogeneity and has been previously associated with 14 different genes. The most common causal genes
mutated in about 60% of ARVC patients include PKP2, DSP, DSG2, DSC2, and JUP, which all encode desmosomal protein components. Rare non-desmosomal variants in TMEM43, TTN, TGFB3, RYR2, PLN, LMNA, DES,
and CTNNA3 comprise less than 1% of all ARVC cases and have been reported in only a few families or clustering
in specific areas, such as TMEM43 in Newfoundland, Canada, and PLN in The Netherlands5,6.
While monoallelic mutations in desmosomal protein-encoding genes, such as DSC2, DSP and JUP, have
been associated with isolated (non-syndromic) ARVC, biallelic mutations in these genes have been reported
with concomitant phenotypes of ARVC and integumentary abnormalities, such as palmoplantar keratoderma
(PPK) and woolly hair and/or alopecia7–10 (Table 1). The cardiocutaneous syndrome, Naxos disease, results from
a two-base pair homozygous deletion in the plakoglobin gene, while its related variant, Carvajal syndrome, which
shows greater left ventricular predominance, is due to a mutation in the desmoplakin gene. Furthermore, biallelic
JUP mutations were reported in association with skin fragility in the spectrum of epidermolysis bullosa (EB),
PPK, woolly hair and/or alopecia, and nail dystrophy. The prevalence of cardiac manifestations in these patients
has remained uncertain because ARVC is a progressive disease that often does not become manifest until the
3rd or 4th decade of life. Patients with homozygous mutations, however, present earlier with 100% penetrance
by adolescence11. Although the original report of biallelic JUP mutations indicated a complete penetrance in
cardiac manifestations, the subsequent studies have reported variable outcomes: among seven patients reported
in one study, only one patient progressed to left-sided dilated cardiomyopathy (DCM) by 19 years of age11,12;
demise of two patients early after birth has been reported13,14; and several patients presented with neither ARVC
nor any other cardiac a bnormalities15. Therefore, genotype–phenotype correlations regarding the penetrance,
age of onset, and variable phenotypes, specifically cardiac involvement in biallelic loss-of-function (LOF) JUP
mutations has not been well established (Table 1).
JUP encodes junction plakoglobin, also known as γ-catenin, an intracellular adapter protein that connects
intermediate filaments to cadherins in desmosomes. Cell–cell adhesion complexes are abundant in tissues subjected to high levels of mechanical stress, such as the epidermis and the heart muscle16. In cardiomyocytes,
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plakoglobin plays a key role not only for anchorage of the myofibrillar apparatus to adherens junctions but
also for myofibrillar compliance. Abnormal plakoglobin can cause desmosomal dysfunction, elevated degree of
cardiac muscle stiffness, and increased total wall stress17.
As part of an effort to characterize a large cohort of patients with skin fragility disorders in the spectrum
of EB patients in Iran, a country consisting of 80 million inhabitants with approximately 38% consanguineous
marriages, patients with clinical presentations suggestive of different EB subtypes were subjected to genomewide sequence analyses. Among the 362 genetically distinct families diagnosed with EB, two patients with a
homozygous JUP mutation were found and are reported here.

Methods

Patient data. This study was approved by the Institutional Review Board of the Pasteur Institute of Iran.

All subjects and the parents of child-subjects gave written informed consent to participate in this research and
to allow their image to be published. All methods were performed in accordance with the relevant guidelines
and regulations. A total of 362 patients from Iran were subjected to mutational analysis. The criterion for study
inclusion was a tentative diagnosis of EB based on history of neonatal cutaneous blistering suggestive of a genetic
skin fragility disorder18–20.

Targeted next‑generation sequencing panel. We developed a disease-specific, gene-targeted panel
for next-generation sequencing to identify pathogenic variants in EB. This panel includes 21 distinct genes, 18
of which have been shown to harbor causative mutations in EB and three of which have been implicated in differential diagnosis of skin fragility disorders18. We tested this panel in a group of patients who are representative
of a large multiethnic cohort of EB patients in Iran. Most patients had an undefined EB subtype, and in some
cases only archived DNA was available. DNA was extracted from peripheral blood samples, taken from patients,
their parents, and other clinically affected and unaffected family members, including siblings (if available), using
a QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA) or the salting-out method. For DNA, target enrichment
was performed using the TruSeq Custom Amplicon kit (Illumina Inc., San Diego, CA). DesignStudio (Illumina
Inc.) was used for library design. All exons, at least 20 base pairs of the intron at each intron–exon boundary, and
up to 50 base pairs of 5′- and 3′-UTRs were targeted. The designed library contained the genes CD151, CDSN,
CHST8, COL17A1, COL7A1, DSP, DST, EXPH5, FERMT1, ITGA3, ITGA6, ITGB4, JUP, KRT5, KRT14, LAMA3,
LAMB3, LAMC2, PKP1, PLEC, and TGM5, divided into 421 targets covered by 968 amplicon probes which were
designed to cover 99% of the targeted bases. A total of 36,724,892 reads were aligned to the human genome, with
the mean coverage of the target region being × 42418.
Mutation analysis and transcriptome profiling of JUP gene expression by RNA‑Seq.

Total
RNA was extracted from whole skin biopsy obtained from Patient 2 and from six healthy controls using TRIzol
Reagent and quantified on a Nanodrop ND-100 spectrophotometer (Thermo Fisher Scientific, Wilmington,
DE), followed by RNA quality assessment on an Agilent 2200 TapeStation (Agilent Technologies, Palo Alto, CA).
Multiplexed library construction, workflow analysis, and sequencing runs were performed following standard
Illumina protocols (Illumina, Inc., San Diego, CA) using the TruSeq Stranded Total RNA kit with indexes from
Set A (Cat #: RS-122-2301). Paired-end (2 × 75) sequencing reads were generated on the Illumina NextSeq 500
platform and stored in FASTQ format. FASTQ quality was checked using FastQC, and the TruSeq RNA adapter
sequences were removed by Trimmomatic. Alignment and mapping were performed using STAR-2pass (v.
2.5.3a) (https://github.com/alexdobin/STAR/releases) with the human reference genome (GRCh38/hg38) and
GENCODE V27 annotations. In the first pass, an initial alignment was executed, and the splice junction information was collected. This information was then used for the second pass, in which the final alignment was performed. The alignments were sorted, the read group was added, and the corresponding index was created (using
Picard tools). The static images of Sashimi plots were generated using the Integrative Genomic Viewer (https
://software.broadinstitute.org/software/igv/. R programming language (https://www.r-project.org/) was used to
perform the expression analysis and plotting to show the distribution range of expression values of several EB
related genes and representative housekeeping genes in the patients versus the six c ontrols21,22.

Variant interpretation. After mapping the RNA-Seq results with human reference genome (GRCh38/
hg38), the annotated CSV files of whole transcriptome sequencing from the proband was obtained for further
analysis. To find the runs of homozygosity (ROH), we set a threshold of > 2 Mb and selected non-frameshift variants from the CSV file. Further, the sequence variants were filtered from the VCF files for missense, nonsense, and
splice site-affecting variants. Indel variants were filtered for exonic in-frame insertions and deletions, frameshift
mutations, and gained/lost start or stop codon. Additionally, only variants with total frequencies of < 0.001 or
those without frequency data available in Genomes, gnomAD and ExAC databases were e xamined23.
Homozygosity mapping. The single nucleotide polymorphism variants called from RNA-Seq data were
used for homozygosity mapping by PLINK 1.90 beta (http://zzz.bwh.harvard.edu/plink/), and were then overlapped with ROHs in the patient’s genome. Considering the given phenotype, segregation analysis in the family,
and the presence of several ROHs in the patient with consanguineous parents enabled us to identify a likely
pathogenic homozygous variant in JUP in the proband24.

Transmission electron microscopy.

Skin biopsy specimens were cut into small pieces (< 1 mm3) and
fixed in half-strength Karnovsky fixative for 4 h at room temperature. After being washed in 0.1 M phosphate
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Figure 1.  Clinical findings in patients with JUP-associated spectrum of skin fragility. Patient 1 (upper panel):
A 2.5-year-old male manifested with trauma-induced blisters and erosions of the skin; perioral, axillary, plantar,
and antecubital fissures; plantar hyperkeratosis; and absence of hair on his scalp. Patient 2 (lower panel): A
22-year-old female showed trauma-induced blisters and erosions; hyperkeratosis of palms, soles, knees and
elbows; joint contractures of fingers; and absence of hair on her scalp.
buffer (pH 7.4), the samples were immersed in 1.3% aqueous osmium tetroxide (TAAB Laboratories, Berkshire,
UK) for 2 h, incubated in 2% uranyl acetate (Bio-Rad, Hertfordshire, UK), dehydrated in a graded ethanol series,
and then embedded in epoxy resin using propylene oxide (TAAB Laboratories). Ultra-thin sections were stained
with uranyl acetate and lead citrate and examined in a Philips CM10 transmission electron microscope (Philips,
Eindhoven, The Netherlands)25.

Immunofluorescence microscopy.

Skin sections (5 μm) from biopsy from traumatized area obtained
from the patient 1 were air-dried and blocked with diluted normal goat serum (Sigma-Aldrich, Dorset, UK),
and then incubated with mouse monoclonal anti-gamma Catenin antibody (Abcam, ab11506) diluted 1:250 in
phosphate-buffered saline with 30% w/v bovine serum albumin (Sigma-Aldrich). At next step, after washing in
phosphate-buffered saline, we labeled slides with fluorescein isothiocyanate secondary antibodies (Invitrogen,
Paisley, UK). The sections were counterstained with DAPI. By excluding the primary antibody, negative controls
were also generated for this study. We used the same camera and the exposure time (3 s) for image acquisition
of all s ections26.

Results

Case report. Patient 1 was a 2.5-year-old male born at the 34th gestational week to healthy second cousin
once removed consanguineous parents with Iranian-Azeri ancestry (Figs. 1 and 3a). He presented at birth with
ulcers and erosions on the perioral and sacral areas. Several days after birth, an ulcer located posterior to the
right internal malleolus developed (Fig. 1). At current examination, he presented with scattered erosions and
ulcers of the skin, particularly in perioral and axillary areas, as well as plantar fissures; mucosal erosions; palmoplantar keratoderma (PPK); nail dystrophy proceeding to nail loss; and absent scalp hair, eyebrows, and
eyelashes (Fig. 1). He exhibited failure to thrive and turned cyanotic while crying.
The laboratory tests revealed a normal serum zinc level. The electrocardiogram (EKG) and 24-h Holter
monitoring showed sinus tachycardia with inverted T waves in right precordial leads (not shown). Transthoracic echocardiogram displayed normal ventricular ejection fraction, chamber size and motion. The parasternal
long and short axis views of right ventricular outflow tract size (PLAX RVOT/BSA; PSAX RVOT/BSA) were
normal (12.8 mm/m2 and 12.6 mm/m2, respectively). No cardiac abnormalities were found in the parents. The
patient met one major criterion (biallelic JUP mutation) based upon the 2010 modified Task Force Criteria
establishing a possible diagnosis of A
 RVC27.
Patient 2 was an Iranian-Azeri 22-year-old female born at the 33rd week of gestation to healthy second-cousin
consanguineous parents (Fig. 3a). At birth, erosions on the scalp, alopecia, absence of eyebrows and eyelashes,
dystrophic nails, and left-sided congenital clubfoot were noted. At current examination she presented with
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Figure 2.  EKG, CMRI with Gadolinium findings in Patient 2. (a) EKG shows inverted T waves in leads V1,
V2 and V3 (asterisks, major criterion) and a prolonged V3 terminal activation duration (TAD) = 80 ms (minor
criterion). Epsilon waves are absent. (There is also a right arm/left arm limb lead reversal). CMRI shows normal
myocardial thickness and wall motion along with normal left and right ventricular size, volume, and function
(b and c). T2-weighted images (short-TI inversion recovery sequence) in the four-chamber (b) and shortaxis (c) views of the ventricles show neither myocardial edema nor inflammation (d and e). Four-chamber
(d) and short-axis views (e) of the ventricles in late Gadolinium enhancement sequences show no myocardial
enhancement or evidence of myocardial replacement with fibrosis.
manifestations similar to Patient 1, including fragile skin; fissures at skin folds, periorificial areas, and the lateral
canthus of the eyes; PPK; hyperkeratotic plaques and follicular hyperkeratosis on the knees and elbows; subungual
hyperkeratosis; and nail dystrophy (Fig. 1). Alopecia, sparse curly eyebrows and eyelashes, short stature, low
weight, and delay of puberty were also noted. Pruritus and skin fragility had lessened with advancing age. In the
family, elective terminations of two subsequent pregnancies had been conducted.
The EKG showed inverted T waves in right precordial leads (V1, V2, and V3) (Fig. 2a) and prolonged terminal
activation duration in V1 (80 ms). A 24-h Holter monitoring showed no ventricular ectopy. Echocardiography
revealed normal left ventricular ejection fraction (EF), but enlarged RV dimensions. The PLAX RVOT/BSA and
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Figure 3.  Identification of biallelic JUP mutations. (a) Pedigrees of two families with consanguinity. The
proband in each family is indicated by an arrowhead. (b) Identification of the mutation in JUP by analysis
of annotated variants from RNA-Seq data in Patient 2 using bioinformatics filtering steps indicated. (c)
Homozygosity mapping based on RNA-Seq data localized the JUP gene within a homozygosity block of 10.7 Mb
on chromosome 17. (d) Sanger sequencing confirmed the presence of the previously unreported homozygous
mutation, JUP: NM_002230: exon 2, c.201_201delC, p.Ser68Alafs*92, in both probands. (e) Heatmap
visualization of transcriptome analysis revealed markedly reduced level of JUP expression in comparison to
the pool of six healthy controls when compared to other genes associated with EB phenotypes and randomly
selected housekeeping genes. (f) Sashimi plot of the transcriptome profile of the mutant JUP mRNA revealed
normal splicing, indicating lack of exon skipping and/or significant intron retention. (g) Protein visualization of
full-length JUP consisting of 745 amino acids. The mutation identified in this study (red) is predicted to result in
a frameshift and early truncation of the protein. Two previously reported JUP mutations in patients with similar
phenotype are shown (black). The figure was rendered in PyMol (v.2, Schrodinger, New York, NY). For details of
WES, homozygosity mapping, RNA sequencing and protein modeling, see PyMol, http://Rymol.org18,24,28,43.
PSAX RVOT/BSA were 21 mm/m2 and 24 mm/m2, respectively. Cardiac magnetic resonance imaging (CMRI),
with and without Gadolinium, revealed normal myocardial thickness and wall motion, normal chamber size,
volume and function, and no delayed myocardial enhancement (Fig. 2b–e). She met at least two major criteria
(anterior T wave inversion and the JUP mutation) and one minor criterion (TAD > 55 ms) of the 2019 modified
Task Force criteria giving her a definite diagnosis of ARVC27.

Mutation detection. Two different approaches were used for mutation detection. First, DNA-based next-

generation sequencing (NGS) utilized a panel consisting of 21 genes associated with different skin fragility syndromes, including EB18. For targeted NGS, DNA was isolated from peripheral blood samples taken from the
patients, their parents, and other clinically affected and unaffected family members. For details of the library
construction, data capturing and bioinformatics, see the references23,25. The second mutation detection approach
utilized RNA-based NGS via RNA-Seq analysis of a whole skin biopsy from Patient 2 as well as six unrelated
healthy controls. The resulting data derived from transcriptome-wide variant calling (Fig. 3b), whole-genome
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Figure 4.  Immunofluorescence and transmission electron microscopy analysis of skin biopsy from Patient 2. IF
staining for junction plakoglobin (encoded by JUP) shows complete absence of the protein in the epidermis of
the patient (left lower panel) compared to pan-epidermal keratinocyte cell membrane labeling in an unrelated
individual’s healthy skin (left upper panel). Ultrastructurally (right panel), desmosomes appear somewhat small
with pinching off within the intercellular desmosomal plaques (arrows) and widening of the intercellular spaces
between adjacent keratinocytes (asterisks). For technical details see r eference44.
homozygosity mapping (Fig. 3c), gene expression profiling visualized by heatmap (Fig. 3e), and gene-specific
splicing events depicted by Sashimi plot (Fig. 3f), were elicited by using in-house bioinformatics a lgorithms22.
Data analysis revealed the same homozygous mutation in JUP: [NM_002230], exon 2, c.201delC; p.Ser68Ala*92
in both probands, with their parents being heterozygous for the mutation. This previously unreported mutation
was confirmed by bidirectional Sanger sequencing (Fig. 3d). This mutation is not reported in either homozygous
or heterozygous state in gnomAD, GME Variome, ExAC, 1000 Genomes, or Iranome. The mutation was predicted to be pathogenic by Annovar, with a CADD score of 46. The 3D structure of junction plakoglobin protein
is visualized by PyMol (v.2, Schrodringer, New York, NY), and previously reported mutations in patients without
significant clinical cardiac involvement are shown in Fig. 3g28.
Since ARVC has also been associated with mutations in 13 other genes, besides JUP, including PKP2, DSC2,
DSG2, RYR2, SCN5A, TMEM43, DSP, CTNNA3, TGFB3, DES, LMNA, PLN and TTN, the corresponding
sequences were individually checked from the RNA-Seq data, and no pathogenic variants were found in these
genes.

Immunofluorescent staining. Immunofluorescence mapping using antibodies directed against desmosomal proteins (plakophilin-1, plakoglobin, and desmoplakin I/III) revealed essentially absent staining for plakoglobin in the epidermis of Patient 2 in contrast to pan-epidermal labeling at the periphery of keratinocytes in
control skin (Fig. 4).
Electron microscopy. Transmission electron microscopy of the skin in Patient 2 revealed intraepidermal
blistering and keratinocyte lysis adjacent to desmosomal plaques (Fig. 4). Since the tissue separation is intraepidermal, these findings place these patients into the simplex category of EB.

Discussion

In this study, we reported two patients from unrelated families residing in different parts of Iran harboring a
homozygous mutation in the JUP gene. They both presented with skin fragility, PPK, alopecia and nail dystrophy, but ECG abnormalities were present only in the older patient. Neither had significant symptoms or family
history for arrhythmia or heart failure. The significant age difference between the two patients provided us the
opportunity to follow the progression of cardiac involvement in patients with the same biallelic mutation in
JUP with time.
Literature review suggested full penetrance (100%) of ARVC in patients with biallelic JUP mutations, specifically p.Arg265His, p.Glu301Gly, p.Trp680Glyfs*11, and c.2157_2158delTG, presenting with PPK and woolly hair
(Table 1)7,11,29,30. However, there was some degree of uncertainty about the cardiac involvement of the patients
with biallelic JUP mutations presenting with skin fragility in addition to PPK and woolly hair/alopecia12–15.
A biallelic JUP mutation that resulted in p.Ser24* was primarily associated with skin fragility and ectodermal
features without cardiac manifestations in three children from a single family (no. 2 in Table 1)15, although the
eldest one manifested with left dilated cardiomyopathy (DCM) at 19 years of age12. However, it was not mentioned
whether this patient was screened for mutations in any other ARVC/ALVC or DCM-associated genes. Moreover,
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DCM can be caused idiopathically or by other causes, such as viral infections. Another biallelic JUP mutation,
c.468G > A, a synonymous splice site mutation at the exon3/intron 3 border, was associated with skin fragility,
sparse woolly hair, and palmoplantar keratoderma, but no cardiac manifestations were noted in this family with
two toddler siblings (Family 1, Table 1)15. Furthermore, biallelic mutations in JUP, p.Gln184* and p.Gln529*,
were reported with skin fragility, alopecia, and nail dystrophy; the patients died at 18 and 11 days after birth,
respectively13,14. The family of the patient harboring the p.Gln184* mutation consented to post-mortem autopsy,
which revealed interventricular septal defect, patchy perivascular fibrosis, and myocyte dropout14. Review of
the literature suggested that the nonsense and splice site mutations, located in more proximal exons of junction plakoglobin, including exons 2, 3, 4 and 9, manifested with more severe skin fragility as compared to the
frameshift mutations leading to truncated protein in the distal exons, such as exon 12, or missense mutations in
the exons 5 that were not associated with skin fragility (Table 1).
Cardiomyopathy in patients with biallelic JUP mutations, characterized by fibrofatty replacement of myocardium with subsequent ventricular dilatation and systolic dysfunction, carries a poor prognosis due to increased
risk of ventricular arrhythmias and sudden cardiac death although the patients are often asymptomatic at an
early age. Efficient screening of the patients could prevent the catastrophic complications later in life. The current
recommended diagnostic approach for ARVC is non-invasive EKG monitoring and cardiac imaging, including
echocardiography and CMRI2,31. Since most clinical findings alone are neither sensitive nor specific enough, 2010
Task Force criteria were developed to provide guidance on ARVC d
 iagnosis27. Arrhythmogenic right ventricular
cardiomyopathy is now considered within the spectrum of arrhythmogenic cardiomyopathies for which clinically relevant and updated information on genetics and disease mechanism are provided in a 2019 expert consensus statement32,33. The ARVC criteria are composed of six domains including global or regional dysfunction
and structural alteration, histological characterization, repolarization abnormalities, depolarization/conduction
abnormalities, arrhythmias, and family h
 istory27.
In the study by Groeneweg et al., anterior (V1-V3) T wave inversion was found in 74% and prolonged TAD/
epsilon waves were seen in 67% and 15% of patients, respectively, with a definite diagnosis of ARVC34. Inverted
T waves in right precordial leads in an individual beyond 14 years of age, in the absence of right bundle branch
block (RBBB), are found only in 4% of healthy women and 1% of healthy men, thus making it a major criterion
with 47% sensitivity and 96% specificity for ARVC35. Furthermore, the pathogenic mutation in JUP is another
major criterion, which counts for 0.5 to 2 percent of ARVC p
 atients36.
The reason for the enlarged RV on ECHO but not CMRI in Patient 2 is unclear. However, because echocardiographic imaging of the RV can be limited, we based the absence of structural abnormalities on her CMRI.
CMRI plays a major role in the diagnosis of ARVC in early stages. The sensitivity of CMRI is 79–89% for major
and 68–78% for minor ARVC criteria while retaining > 95% s pecificity37. CMRI has some limitations including
inter-observer variability in identifying features of ARVC, and it is therefore recommended that CMRI is assessed
by an expert specialist familiar with this technique37. Moreover, the sensitivity of CMRI in children is low because
arrhythmic presentations precede structural c hanges38. High negative predictive value of Gadolinium-enhanced
CMRI makes it a good choice as a rule-out imaging test for evaluation of structural and functional abnormalities
in patients suspected to have ARVC39.
DSP and JUP mutations accounted for 90.8% of the patients displaying cutaneous phenotype with ARVC40.
Furthermore, most patients harboring a mutation in ARVC-associated genes present with ARVC by 30 years
of age although homozygous patients (e.g., Naxos disease) show 100% penetrance by a dolescence42. Long-term
cardiac monitoring by EKG, Holter monitoring, echocardiography, and exercise stress test is recommended for
the patients harboring mutations in ARVC-associated genes as well as those presenting with PPK and hair shaft
anomalies with unknown genotype; however, it was reported that only 2.3% of patients with such cutaneous
phenotypes receive relevant cardiac m
 onitoring41,42. In this context, because of age-dependent penetrance and
the young age of our patients, further studies and close follow-up are needed, including cardiological monitoring
of family members at risk. Such risk can be assessed by mutation analysis of the members of the extended family.
In conclusion, we examined two unrelated patients with skin fragility, separated in age by 20 years, but who
harbor the same, previously unreported homozygous JUP mutation. Repolarization/depolarization abnormalities and echocardiographic RV enlargement was seen in the older (definite ARVC) but not the younger (possible
ARVC) proband. This cross-sectional observation highlights the age-dependent penetrance of ARVC, the need
for close monitoring of patients with pathogenetic JUP mutations; and cascade screening of first degree at risk
family members.
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